Company intelligence / Profile preview

BioLuster Research Center

Ownership: Private
Development stage: Other

Overview

BioLuster Research Center is a biotechnology research organization focused on the development of innovative therapeutic solutions for age-related diseases and metabolic health. The center specializes in identifying novel compounds and peptide-based interventions aimed at enhancing cellular longevity and metabolic efficiency. By leveraging advanced screening technologies, BioLuster seeks to bridge the gap between fundamental biological research and clinical application. Their current efforts are primarily concentrated in the pre-clinical stage, targeting indications such as neurodegeneration and metabolic syndrome.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on BioLuster Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLuster Research Center.

Explore the full profile